NervGen Pharma (NGENF) Stock Chart & Stock Price History $2.47 +0.01 (+0.41%) As of 08/4/2025 03:54 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock NervGen Pharma Stock Price Performance The NervGen Pharma (NGENF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 24.43%, with a year-to-date return of 13.30%. In the past month, the stock has increased 0.65%, reflecting recent market activity. As of the latest close, NervGen Pharma traded at $2.47 with a market cap of $152.57 million and volume of 51,076 shares. Receive NGENF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NervGen Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.76%1 Month Performance+0.65%3 Month Performance-6.51%Year-To-Date Performance+13.30%1 Year Performance+24.43% NGENF Stock Chart for Tuesday, August, 5, 2025 NGENF Chart by TradingView NervGen Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/04/2025$2.46$2.47+0.41%$2.51$2.4251,076 shs$152.57 million08/01/2025$2.49$2.46-1.17%$2.50$2.4062,017 shs$151.95 million07/31/2025$2.50$2.49-0.42%$2.50$2.4759,428 shs$153.75 million07/30/2025$2.50$2.50-0.02%$2.63$2.4890,023 shs$154.39 million07/29/2025$2.57$2.50-2.72%$2.55$2.4985,266 shs$154.43 million07/28/2025$2.58$2.57-0.39%$2.62$2.5446,944 shs$158.75 million07/25/2025$2.70$2.58-4.44%$2.68$2.55100,374 shs$159.37 million07/24/2025$2.78$2.70-3.02%$2.80$2.6846,899 shs$166.78 million07/23/2025$2.64$2.78+5.45%$2.80$2.6454,393 shs$171.97 million07/22/2025$2.75$2.64-4.00%$2.80$2.62174,717 shs$163.07 million Get the Latest News and Ratings for NGENF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NervGen Pharma and its competitors with MarketBeat's FREE daily newsletter. 07/21/2025$2.70$2.75+1.85%$2.85$2.62140,319 shs$169.87 million07/18/2025$2.76$2.70-2.17%$2.78$2.60195,747 shs$166.78 million07/17/2025$2.84$2.76-2.82%$2.88$2.63132,630 shs$170.49 million07/16/2025$2.91$2.84-2.47%$2.93$2.8086,260 shs$175.43 million07/15/2025$3.03$2.91-3.89%$3.14$2.90105,894 shs$179.87 million07/14/2025$2.89$3.03+4.84%$3.05$2.91103,084 shs$187.16 million07/11/2025$2.94$2.89-1.63%$3.02$2.86120,552 shs$178.52 million07/10/2025$2.73$2.94+7.82%$3.04$2.75114,044 shs$181.48 million07/09/2025$2.58$2.73+5.62%$2.73$2.5762,785 shs$168.32 million07/08/2025$2.59$2.58-0.39%$2.67$2.5868,634 shs$159.37 million07/07/2025$2.45$2.59+5.54%$2.70$2.5095,305 shs$159.98 million07/04/2025$2.45$2.45$2.55$2.4074,801 shs$151.58 million Related Companies CYBN Stock Chart APHB Stock Chart HYPD Stock Chart HEB Stock Chart IBIO Stock Chart PHGE Stock Chart BRTX Stock Chart PHXM Stock Chart LIAN Stock Chart ADIL Stock Chart Receive NGENF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NervGen Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:NGENF) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NervGen Pharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share NervGen Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
